Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor

Background: Single-agent amrubicin chemotherapy is a key regimen, especially for small cell lung cancer (SCLC); however, it can cause severe myelosuppression. Purpose: The purpose of this study was to determine the real-world incidence of febrile neutropenia (FN) among patients treated with single-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dotsu, Yosuke, Yamaguchi, Hiroyuki, Fukuda, Minoru, Suyama, Takayuki, Honda, Noritaka, Umeyama, Yasuhiro, Taniguchi, Hirokazu, Gyotoku, Hiroshi, Takemoto, Shinnosuke, Tagawa, Ryuta, Ogata, Ryosuke, Tomono, Hiromi, Shimada, Midori, Senju, Hiroaki, Nakatomi, Katsumi, Nagashima, Seiji, Soda, Hiroshi, Ikeda, Hiroaki, Ashizawa, Kazuto, Mukae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464789/
https://www.ncbi.nlm.nih.gov/pubmed/34575334
http://dx.doi.org/10.3390/jcm10184221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464789/
https://www.ncbi.nlm.nih.gov/pubmed/34575334
http://dx.doi.org/10.3390/jcm10184221

Ejemplares similares